GLP-1R Agonist Treatment for Opioid Use Disorder
Abroad (travel likely)RecruitingPHASE2
Conditions
Opioid Use Disorder · Opioid Abuse and Addiction · Narcotic-Related Disorders · Substance-Related Disorders · Chemically-Induced Disorders · Mental Disorder · Opioid
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Maryland Baltimore, Baltimore, Maryland, United States
Contact: Principal Investigator (Eric Weintraub, MD)NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (Mathew Kladney, MD)Pennsylvania Psychiatric Institute, Harrisburg, Pennsylvania, United States
Contact: Principal Investigator (Sarah Kawasaki, MD)
Study leads
Jennifer Nyland, PhD
Principal Investigator
Milton S. Hershey Medical Center